Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
about
Exogenous endophthalmitis in diabetic patients: a systemic reviewEndophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive reviewAntibioprophylaxis in Prevention of Endophthalmitis in Intravitreal Injection: A Systematic Review and Meta-AnalysisEffects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injectionsOcular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degenerationAdvances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research NetworkProphylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate.Postinjection endophthalmitis in the comparison of age-related macular degeneration treatments trials (CATT)Comment on bilateral same-session intravitreal injections.Combination of vascular endothelial growth factor inhibitors and laser therapy for diabetic macular oedema: a review.Topical azithromycin or ofloxacin for endophthalmitis prophylaxis after intravitreal injectionUpdate on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.Intravitreal injections: a review of the evidence for best practice.Prevention and treatment of injection-related endophthalmitis.Complications of intravitreal injections in patients with diabetes.Current Perspectives of Prophylaxis and Management of Acute Infective Endophthalmitis.Topical antibiotics and intravitreal injections.Study of the Acute Effects of Povidone-Iodine on Conjunctival Bacterial FloraSimultaneous Therapy with Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema.Transporter targeted gatifloxacin prodrugs: synthesis, permeability, and topical ocular delivery.Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection.Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.Postoperative endophthalmitis incidence after intravitreal therapy: a comparison of two different preoperative antibiotic prophylaxis.Intravitreal Injection of Bevacizumab: Review of our previous ExperienceRole of topical antibiotics in prophylaxis against endophthalmitis following intravitreal antibioticsCausative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents
P2860
Q26859314-B078D3F2-E5F6-4891-B2E6-4ADF0529115DQ28084070-5F1AFCD1-FDF9-40E8-8C3F-F245DFF2AF67Q28276112-DBDDE05D-2CD1-4AC1-AD78-9A1A9D7BB0E7Q34390583-94F69630-011A-42D5-AAB9-64AEE2B7A0EDQ35127099-39BC385B-D7B3-4B1A-92E8-49B2EB13CFBAQ35649512-4AF0D15B-A70A-4B81-B291-2A8C6DE7AC74Q35693314-855DCB16-CDEF-497B-A2CC-2CCA3B9BD229Q35742777-47134E8C-F0AD-4DA4-A2A8-E70C5B99F710Q35964534-631901B3-C663-4A0B-8B9A-2BE0F664995BQ35984696-FD34A36D-52A8-465A-9C6C-AA0DF694F896Q36326803-8B2C03D1-8C5E-40C4-8136-C67E4B4931CDQ36371395-2B20421C-3CFC-4C66-8AE2-94BE45427501Q36762577-79F9807E-BAA0-4883-96C4-D07330FBF752Q37763847-99479563-C89E-4FDD-AAEB-7DF649710A19Q37910660-5F23FC56-120A-4003-87D7-8A8B44A8FE54Q38053198-221CFA5D-D3C3-4F85-BE0D-5B13408E7BBDQ38210130-D879A10D-9AAE-4B40-BA8C-AC8801FF2FCFQ38261106-6995FF1D-D0C0-4F88-BE8C-F4021627718AQ38758366-D36B4B6E-141E-42D9-89CA-75CA238FFA31Q39261103-EB742BA6-DB27-435D-87B6-F075A78BB4CBQ41044420-A8933AA6-C231-4DCF-8084-60383BB75AABQ41809125-3A58C9F9-92F4-4145-ABEB-D19E68370C78Q41841013-8A0CC97E-1933-43FF-BA98-7B518B40432BQ42276004-00B5AE31-42E9-4FA5-B531-E824F0B5ED79Q42324331-802599A2-6202-4203-A675-60B18C42B939Q45875451-B8865ABE-0DEA-43DE-A513-1176E3C6AD84Q51537659-1A363BE1-4C41-4EA0-80DF-40E6C356A99AQ57178289-8135673E-2593-4330-B9FE-BDDA1D0D8C35Q57822957-CACE3FDF-C52D-4AF3-AA8D-FAD8EA149486Q58784488-38F1C936-96CB-4C4B-BD1F-112C6C45C601
P2860
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@ast
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@en
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@nl
type
label
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@ast
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@en
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@nl
prefLabel
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@ast
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@en
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@nl
P2093
P2860
P1433
P1476
Risk of endophthalmitis after ...... triamcinolone clinical trials.
@en
P2093
Abdhish R Bhavsar
Adam R Glassman
Alexander J Brucker
Cynthia R Stockdale
Diabetic Retinopathy Clinical Research Network
Joseph M Googe
Michael J Elman
Neil M Bressler
P2860
P304
P356
10.1001/ARCHOPHTHALMOL.2009.304
P407
P577
2009-12-01T00:00:00Z